Table 1.

Pretreatment characteristics of the s-IVB, m-IVB and PDT groups

	s-IVB group	m-IVB group	PDT group	P value
Number of eyes	18	22	49
Women/Men	1/17	5/17	7/42	0.309
Age (years)	72.9±5.7	73.0±8.9	69.6±7.8	0.131
BCVA (logMAR units)	0.54±0.37	0.53±0.34	0.54±0.29	0.992
Foveal thickness (μm)	427.9±190.2	438.8±234.7	438.5±192.3	0.981
GLD (μm)	3366±992	3651±1833	3718±1665	0.726

s-IVB: Single intravitreal bevacizumab, m-IVB: Monthly intravitreal bevacizumab, PDT: Photodynamic therapy, BCVA: Best-corrected visual acuity, GLD: Greatest linear dimension